Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,734 public trials 875 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Completed

A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States

NCT00724867

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Long Beach, California, United States
View all 51 locations
View Trial Details
Completed

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

NCT01651143

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Investigational Site Number 840006 Scottsdale, Arizona, United States
  • Investigational Site Number 840003 Washington D.C., District of Columbia, United States
  • Investigational Site Number 840004 Baltimore, Maryland, United States
  • Investigational Site Number 840001 Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid Arthritis

NCT01244958

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Schwerpunktpraxis Bad Kösen, Saxony-Anhalt, Germany
  • Kerckhoff-Klinik GmbH Abtlg. Rheumatologie und Klin. Immunologie Bad Nauheim, Germany
  • Rheumazentrum Baden-Baden Baden-Baden, Germany
  • Praxis Remstedt Berlin, Germany
View all 45 locations
View Trial Details
Completed

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

NCT02228850

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +11 more
Locations
  • Diagnamics, Inc. Encinitas, California, United States
  • University of Michigan Scleroderma Program - Division of Rheumatology/Dept. of Internal Medicine Ann Arbor, Michigan, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Scleroderma Research Center - University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions